Ensign Group [ENSG] vs Encompass Health [EHC] Detailed Stock Comparison
Ensign Group
NASDAQ
Loading...
Encompass Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ensign Group wins in 4 metrics, Encompass Health wins in 16 metrics, with 0 ties. Encompass Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ensign Group | Encompass Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.83 | 24.02 | Encompass Health |
| Price-to-Book Ratio | 4.98 | 5.45 | Ensign Group |
| Debt-to-Equity Ratio | 100.93 | 86.97 | Encompass Health |
| PEG Ratio | 1.82 | 0.97 | Encompass Health |
| EV/EBITDA | 23.81 | 12.32 | Encompass Health |
| Profit Margin (TTM) | 7.00% | 9.22% | Encompass Health |
| Operating Margin (TTM) | 8.46% | 17.77% | Encompass Health |
| EBITDA Margin (TTM) | 8.46% | 17.77% | Encompass Health |
| Return on Equity | 17.54% | 24.72% | Encompass Health |
| Return on Assets (TTM) | 5.30% | 9.18% | Encompass Health |
| Free Cash Flow (TTM) | $188.95M | $360.30M | Encompass Health |
| Dividend Yield | 0.18% | 0.55% | Encompass Health |
| 1-Year Return | 19.87% | 30.46% | Encompass Health |
| Price-to-Sales Ratio (TTM) | 2.19 | 2.19 | Encompass Health |
| Enterprise Value | $11.67B | $15.81B | Encompass Health |
| EV/Revenue Ratio | 2.53 | 2.79 | Ensign Group |
| Gross Profit Margin (TTM) | 16.19% | 43.01% | Encompass Health |
| Revenue per Share (TTM) | $81 | $57 | Ensign Group |
| Earnings per Share (Diluted) | $5.51 | $5.13 | Ensign Group |
| Beta (Stock Volatility) | 0.93 | 0.80 | Encompass Health |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Ensign Group vs Encompass Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ensign Group | -0.41% | 2.16% | 1.37% | 19.60% | 41.62% | 32.84% |
| Encompass Health | 1.28% | -1.43% | -0.60% | 4.87% | 29.46% | 36.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ensign Group | 19.87% | 112.91% | 204.21% | 786.93% | 3,687.55% | 4,183.98% |
| Encompass Health | 30.46% | 166.16% | 131.25% | 304.52% | 765.84% | 673.32% |
News Based Sentiment: Ensign Group vs Encompass Health
Ensign Group
News based Sentiment: POSITIVE
October was a strong month for Ensign Group, marked by an analyst upgrade, a new all-time high stock price, and continued positive financial performance. These developments indicate a healthy and growing business, making it an attractive investment for those seeking both income and growth.
Encompass Health
News based Sentiment: POSITIVE
October proved to be a strong month for Encompass Health, with robust Q2 earnings exceeding expectations, increased analyst price targets, and continued expansion efforts. While some stock price declines and a legal investigation exist, the overall narrative points towards positive momentum and future growth potential, making it a significant month for investors.
Performance & Financial Health Analysis: Ensign Group vs Encompass Health
| Metric | ENSG | EHC |
|---|---|---|
| Market Information | ||
| Market Cap | $10.12B | $12.63B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 291,431 | 581,540 |
| 90 Day Avg. Volume | 354,167 | 643,327 |
| Last Close | $176.50 | $125.20 |
| 52 Week Range | $118.73 - $179.11 | $87.85 - $127.86 |
| % from 52W High | -1.46% | -2.08% |
| All-Time High | $179.11 (Oct 06, 2025) | $127.86 (Sep 23, 2025) |
| % from All-Time High | -1.46% | -2.08% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.12% |
| Quarterly Earnings Growth | 0.19% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.09% |
| Operating Margin (TTM) | 0.08% | 0.18% |
| Return on Equity (TTM) | 0.18% | 0.25% |
| Debt to Equity (MRQ) | 100.93 | 86.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.23 | $22.60 |
| Cash per Share (MRQ) | $7.30 | $0.98 |
| Operating Cash Flow (TTM) | $462.89M | $1.11B |
| Levered Free Cash Flow (TTM) | $30.01M | $261.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.18% | 0.55% |
| Last 12-Month Dividend | $0.30 | $0.66 |
Valuation & Enterprise Metrics Analysis: Ensign Group vs Encompass Health
| Metric | ENSG | EHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.83 | 24.02 |
| Forward P/E | 28.57 | 25.78 |
| PEG Ratio | 1.82 | 0.97 |
| Price to Sales (TTM) | 2.19 | 2.19 |
| Price to Book (MRQ) | 4.98 | 5.45 |
| Market Capitalization | ||
| Market Capitalization | $10.12B | $12.63B |
| Enterprise Value | $11.67B | $15.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.53 | 2.79 |
| Enterprise to EBITDA | 23.81 | 12.32 |
| Risk & Other Metrics | ||
| Beta | 0.93 | 0.80 |
| Book Value per Share (MRQ) | $35.23 | $22.60 |
Financial Statements Comparison: Ensign Group vs Encompass Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ENSG | EHC |
|---|---|---|
| Revenue/Sales | $1.23B | $1.46B |
| Cost of Goods Sold | $1.03B | $824.50M |
| Gross Profit | $198.79M | $630.90M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $103.90M | $267.00M |
| EBITDA | $140.17M | $349.60M |
| Pre-Tax Income | $112.36M | $238.60M |
| Income Tax | $27.89M | $41.60M |
| Net Income (Profit) | $84.47M | $196.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ENSG | EHC |
|---|---|---|
| Cash & Equivalents | $282.67M | $95.80M |
| Total Current Assets | $986.39M | $910.90M |
| Total Current Liabilities | $705.21M | $856.00M |
| Long-Term Debt | $1.91B | $2.54B |
| Total Shareholders Equity | $1.93B | $2.94B |
| Retained Earnings | $1.50B | $930.80M |
| Property, Plant & Equipment | $2.32B | $3.94B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ENSG | EHC |
|---|---|---|
| Operating Cash Flow | $97.90M | $289.30M |
| Capital Expenditures | $-42.93M | $-163.10M |
| Free Cash Flow | $29.29M | $125.50M |
| Debt Repayment | $-1.01M | $-80.00M |
| Common Stock Repurchase | $-10.79M | $-32.10M |
Short Interest & Institutional Ownership Analysis
| Metric | ENSG | EHC |
|---|---|---|
| Shares Short | 1.84M | 1.46M |
| Short Ratio | 5.40 | 2.25 |
| Short % of Float | 0.04% | 0.02% |
| Average Daily Volume (10 Day) | 291,431 | 581,540 |
| Average Daily Volume (90 Day) | 354,167 | 643,327 |
| Shares Outstanding | 57.44M | 100.78M |
| Float Shares | 55.24M | 99.22M |
| % Held by Insiders | 0.03% | 0.01% |
| % Held by Institutions | 0.98% | 0.97% |
Dividend Analysis & Yield Comparison: Ensign Group vs Encompass Health
| Metric | ENSG | EHC |
|---|---|---|
| Last 12-Month Dividend | $0.30 | $0.66 |
| Last 12-Month Dividend Yield | 0.18% | 0.55% |
| 3-Year Avg Annual Dividend | $0.26 | $3.68 |
| 3-Year Avg Dividend Yield | 0.05% | 1.66% |
| 3-Year Total Dividends | $0.78 | $11.04 |
| Ex-Dividend Date | Sep 30, 2025 | Apr 01, 2025 |